Frontline Treatment Strategies in EGFR-Mutant NSCLC
EP. 1: A Case of EGFR-Mutant Non-Small Cell Lung Cancer
Watch
EP. 2: Shifting Prognoses of Patients With EGFR-Mutant NSCLC
EP. 3: EGFR-Mutant NSCLC: Optimizing Therapy Selection
EP. 4: Systemic Therapy Options for Non-Small Cell Lung Cancer
EP. 5: Osimertinib's Value in EGFR-Mutant NSCLC
EP. 6: EGFR-Mutant NSCLC: Selecting Patients for Osimertinib
EP. 7: Optimizing Therapy at Progression of EGFR-Mutant NSCLC
